JW Pharmaceutical Corp
KRX:001060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JW Pharmaceutical Corp
Gain/Loss on Disposition of Assets
JW Pharmaceutical Corp
Gain/Loss on Disposition of Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gain/Loss on Disposition of Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp
KRX:001060
|
Gain/Loss on Disposition of Assets
-₩46.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
53%
|
CAGR 10-Years
36%
|
|
|
Yuhan Corp
KRX:000100
|
Gain/Loss on Disposition of Assets
₩62.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gain/Loss on Disposition of Assets
-₩194.8m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
-268%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gain/Loss on Disposition of Assets
₩101.2m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gain/Loss on Disposition of Assets
₩441.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Gain/Loss on Disposition of Assets
₩10.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
JW Pharmaceutical Corp
Glance View
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.
See Also
What is JW Pharmaceutical Corp's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
-46.8m
KRW
Based on the financial report for Dec 31, 2025, JW Pharmaceutical Corp's Gain/Loss on Disposition of Assets amounts to -46.8m KRW.
What is JW Pharmaceutical Corp's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 10Y
36%
